Werewolf Therapeutics Inc. (HOWL)
NASDAQ: HOWLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
HOWL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $44.23M
- EPS (TTM)
- -$0.73
- Dividend yield
- None
- 52-week range
- 0.27 – 1.94
- Day range
- 0.907 – 0.9281
- Volume / Avg
- 631.35K / 6.80M
- Beta
- —
- Shares outstanding
- 48.60M
- Next earnings
- Nov 3, 2026
52-week range
HOWL stock today
Werewolf Therapeutics (HOWL) closed at $0.91 on Oct 8, down 1.10% (-$0.0101), versus the S&P 500's 0.47% decline. Trading was light, with 631.35K shares changing hands, about 9% of the average daily volume. At this level, HOWL sits in the middle of its 52-week range of $0.27 to $1.94: 53.0% below the high and 237.0% above the low.
HOWL is up 45.1% year to date, outperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 52.3%. Werewolf Therapeutics has posted a net loss over the last twelve months (EPS of -$0.73), so its P/E ratio is not meaningful. Werewolf Therapeutics's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Werewolf Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 3, 2026
HOWL news
All HOWL newsWerewolf Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRCEGrace Therapeutics Inc. | 2.04 | -2.86% | $42.91M | vs HOWL |
| NSRXNasus Pharma Ltd. | 3.63 | -3.84% | $42.52M | vs HOWL |
| CELUCelularity Inc. Class A | 1.46 | -0.68% | $47.38M | vs HOWL |
| SCYXSCYNEXIS Inc. | 4.22 | -11.72% | $41.99M | vs HOWL |
| ELTXElicio Therapeutics Inc. | 1.81 | -2.16% | $47.57M | vs HOWL |
| DWTXDogwood Therapeutics Inc. | 1.41 | -1.40% | $47.93M | vs HOWL |
| CPHIChina Pharma Holdings Inc. | 0.96 | +12.94% | $41.30M | vs HOWL |
| VERUVeru Inc. | 2.42 | -1.63% | $41.26M | vs HOWL |
Indexes, lists and sector
Werewolf Therapeutics stock FAQ
What is Werewolf Therapeutics's stock price today?
HOWL last traded at $0.91 as of Oct 8, 4:00 PM EDT, down 1.10% on the day. Prices are delayed at least 15 minutes.
When is Werewolf Therapeutics's next earnings date?
Werewolf Therapeutics is expected to report earnings on Tuesday, November 3, 2026.
What is the HOWL 52-week high?
The 52-week high for HOWL is $1.94 and the 52-week low is $0.27. The stock is currently 53.0% below its high.